-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on VolitionRX, Lowers Price Target to $1

Benzinga·04/02/2026 16:06:10
Listen to the news
HC Wainwright & Co. analyst Yi Chen maintains VolitionRX (AMEX:VNRX) with a Buy and lowers the price target from $1.5 to $1.